Ozaki Y Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by FDG-PET

[1]  F. Chierichetti,et al.  F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: A prospective study , 2007, Journal of Gastrointestinal Surgery.

[2]  T. Shimosegawa,et al.  Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal , 2006, Journal of Gastroenterology.

[3]  M. Nagino,et al.  Intense PET signal in the degenerative necrosis superimposed on chronic pancreatitis. , 2005, Pancreas.

[4]  M. Schäfer,et al.  Positron Emission Tomography/Computed Tomography Influences on the Management of Resectable Pancreatic Cancer and Its Cost-Effectiveness , 2005, Annals of surgery.

[5]  Brady K. Huang,et al.  Pancreatic pseudocyst observed on F-18 FDG PET imaging. , 2005, Clinical nuclear medicine.

[6]  Ludwig G. Strauss,et al.  Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients , 1996, European Journal of Nuclear Medicine.

[7]  K. Shiratori,et al.  Chronic pancreatitis caused by an autoimmune abnormality , 1995, Digestive Diseases and Sciences.

[8]  W. Oyen,et al.  FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  H. Sakai,et al.  Autoimmune Pancreatitis as a New Clinical Entity (Three Cases of Autoimmune Pancreatitis with Effective Steroid Therapy) , 1997, Digestive Diseases and Sciences.

[10]  O. Sabri,et al.  Fluorine-18 fluorodeoxyglucose positron mission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases , 1997, European Journal of Nuclear Medicine.

[11]  M. Kadoya,et al.  Hilar and Pancreatic Gallium-67 Accumulation is Characteristic Feature of Autoimmune Pancreatitis , 2003, Pancreas.

[12]  T. Saga,et al.  Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) —Usefulness and limitations in “clinical reality”— , 2003, Annals of nuclear medicine.

[13]  A. Luxen,et al.  Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  S. Kawa,et al.  Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis , 2002, The Lancet.

[15]  S. Kawa,et al.  ERCP features in 27 patients with autoimmune pancreatitis. , 2002, Gastrointestinal endoscopy.

[16]  J. Cameron,et al.  Pancreaticoduodenectomy (Whipple Resections) in Patients Without Malignancy , 2002 .

[17]  T. Nikaido,et al.  High serum IgG4 concentrations in patients with sclerosing pancreatitis. , 2001, The New England journal of medicine.

[18]  H. Sakahara,et al.  Delayed 18F‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas , 2000, Cancer.

[19]  H. Sakahara,et al.  FDG-PET of autoimmune-related pancreatitis: preliminary results , 2000, European Journal of Nuclear Medicine.

[20]  B. Diamond,et al.  Autoimmune diseases , 2000, Bone Marrow Transplantation.

[21]  W. Chapman,et al.  Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  Higashi,et al.  Autoimmune pancreatitis with F-18 fluoro-2-deoxy-D-glucose PET findings , 1999, Clinical nuclear medicine.

[23]  G. Glatting,et al.  F-18 Fluorodeoxyglucose (FDG) and C-Reactive Protein (CRP). , 1999, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[24]  E. Nitzsche,et al.  Evaluation of positron emission tomography with 2‐[18F]fluoro‐2‐deoxy‐D‐glucose for the differentiation of chronic pancreatitis and pancreatic cancer , 1999, The British journal of surgery.

[25]  P. Shreve.  Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease , 1998, European Journal of Nuclear Medicine.

[26]  S. Kawa,et al.  Characteristic Pancreatic Duct Appearance in Autoimmune Chronic Pancreatitis: A Case Report and Review of the Japanese Literature , 1998, American Journal of Gastroenterology.

[27]  Y. Yonekura,et al.  Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US. , 1995, Radiology.

[28]  S. Hauptmann,et al.  F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. , 1994, Radiology.

[29]  T Ido,et al.  Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.